VCP and cardiovascular disorder: Given the increasing importance of extracellular vesicles in cardiovascular disease (Yin et al., 2015; Chen et al., 2018; Badimon et al., 2017), these variations in TERA levels should be further studied as they could be indicative of differential tissue and/or cell vesicle release during the development of CAS.